𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

✍ Scribed by Dario Baratti; Elisabetta Pennacchioli; Shigeki Kusamura; Marco Fiore; Maria Rosaria Balestra; Chiara Colombo; Elvira Mingrone; Gronchi Alessanrdro; Marcello Deraco

Book ID
111773693
Publisher
Springer
Year
2010
Tongue
English
Weight
260 KB
Volume
17
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hyperthermic intraoperative intraperiton
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis : Phase I study
✍ Carlo R. Rossi; Mirto Foletto; Simone Mocellin; Pierluigi Pilati; Michele De Sim πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract ## BACKGROUND Hyperthermic intraperitoneal intraoperative chemotherapy (HIIC) combined with cytoreductive surgery (CS) has been proposed as a new multimodal treatment mainly for carcinomatosis of gastrointestinal origin. To evaluate whether this regimen could be used for other tumor ty

Results of cytoreductive surgery and hyp
Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer
✍ Gabriel Glockzin; Nabil Ghali; Sven A. Lang; Hans J. Schlitt; Pompiliu Piso πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significa